Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02817438 · ClinicalTrials.gov registry record · NA
Research on Anxiety and Depression: Computer-Assisted Therapy
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 136
- Enrollment target
NCT02817438: Completed NA study, sponsored by Stanford University.
NCT02817438 is a NA study that has completed, run by Stanford University. The registered enrollment target is 136 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02817438, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 136 participants
- Enrollment target
Study Summary
This study examines how online self-guided programs can improve mood and anxiety symptoms. These programs use exercises from Cognitive-Behavioral Therapy, which is an evidence-based treatment for depression and anxiety. The purpose of this study is to learn who will do best with the online format. Our aim is to learn for whom online self-guided interventions are most efficacious. This knowledge is important because it will help inform clinicians and patients about who might benefit from this type of intervention versus who would need the assistance of a therapist. More specifically, we hope to figure out who would benefit from solely an online intervention and who would benefit from an online intervention in addition to other treatment.
Primary Outcome
Composite score combining 3 measures of depression and/or anxiety (PHQ-9, BAI, DASS)
Interventions
- BEHAVIORAL Good Days Ahead
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 136 participants |
| Start Date | 2016-06 |
| Est. Completion | 2018-03 |
| Phase | NA |
What the finished NCT02817438 record still lists
NCT02817438 is an interventional study that assigns participants to a tested intervention. The registered 136 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 1 intervention - of which Good Days Ahead is the first listed.
NCT02817438 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02817438 about?
NCT02817438 is a clinical study titled "Research on Anxiety and Depression: Computer-Assisted Therapy". This study examines how online self-guided programs can improve mood and anxiety symptoms. These programs use exercises from Cognitive-Behavioral Therapy, which is an evidence-based treatment for depression and anxiety. The purpose of this study is to learn who will do best with the online format. O...
What is the current status of trial NCT02817438?
This trial is currently completed. It is a NA study. The enrollment target is 136 participants. The study started on 2016-06. Estimated completion is 2018-03.
What interventions are being tested in trial NCT02817438?
The interventions under investigation include: Good Days Ahead (BEHAVIORAL).
Who is sponsoring clinical trial NCT02817438?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02817438's enrollment target sits among peer trials
136 722nd of 2000 higher than 1,275 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01555892 · 136 participants · Phase 1
Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE
- NCT03216525 · 136 participants · Phase 3
Alvimopan Versus Placebo in Patients Undergoing Radical Cystectomy on an Enhanced Recovery Protocol
- NCT04476901 · 136 participants · Phase 2
Administration of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy
- NCT04603898 · 136 participants · NA
Oxalate Formation From Ascorbic Acid
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia